-+ 0.00%
-+ 0.00%
-+ 0.00%

SPYGLASS PHARMA ANNOUNCES POSITIVE TOPLINE 12-MONTH PHASE 1/2 TRIAL RESULTS FOR ITS INNOVATIVE BIM-IOL SYSTEM

Reuters·03/09/2026 12:00:00

Please log in to view news